Cases
CourtFilingsPetition dateMore filters
Chapter 11 · Filed Jun 23, 2026
Sangamo is in the post-sale phase of its Chapter 11 case: the Merope sale transaction closed on September 4, with specified contracts assumed and assigned and specified outbound license agreements rejected, while the debtor continues to shed remaining operating costs. Notice of Closing of Merope Sale TransactionDkt. 436
Updated Sep 5, 4:43 PM ET
Next: Sep 21, 1:00 PM ET · Claims & Administration
Exhibit(s) // Notice of (I) Closing of Merope Sale Transaction, (II) Assumption and Assignment of the Acquired Contracts, and (III) Rejection of the Rejected Outbound License Agreements (related document(s)[122], [139], [165], [209], [362], [364]) Filed by Sangamo Therapeutics, Inc.. (Attachments: # (1) Exhibit 1a # (2) Exhibit 1b # (3) Exhibit 2a # (4) Exhibit 2b) (McCauley, James)
Dkt. 436 · Sep 4, 2026
Supplemental Certificate of Service re: 1) Notice of Cure Amounts and Potential Assumption and Assignment and/or Rejection of Executory Contracts and Unexpired Leases in Connection with Sale of Substantially All Assets; 2) Notice of Deadlines for Filing Proofs of Claim (Including for Administrative Expense Claims Arising Under Section 503(b)(9) of the Bankruptcy Code); and 3) Modified Official Form 410 Proof of Claim (related document(s)[139], [185], [209], [210], [316]) Filed by Kurtzman Carson Consultants, LLC dba Verita Global. (Kass, Albert)
Dkt. 435 · Sep 3, 2026
Transfer/Assignment of Claim. Transfer Agreement 3001 (e) 2 Transferors: CYGNUS Technologies (Claim No. 43, Amount $8,934.31) To Argo Partners. Filed by Argo Partners. (Singer, Michael)
Dkt. 432 · Sep 3, 2026
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.